25 November 2022
As part of World Antimicrobial Awareness Week, the Ineos Oxford Institute for Antimicrobial Research and Oxford Martin School hosted a symposium on 'The Rising Tide of Antimicrobial Resistance: A high price to pay', bringing together experts from research, industry, policy and finance to discuss the threat and opportunities to address it.
22 November 2022
A new study, led by researchers from the Department of Biology and released during World Antimicrobial Awareness Week, has significant findings on how antimicrobial resistance (AMR) arises and persists.
3 November 2022
A new study, involving researchers in the departments of Chemistry and Biochemistry and the Kavli Institute, sheds light on how Gram-negative bacteria like E. coli construct their outer membrane to resemble body armour, which has far-reaching implications for the development of antibiotics.
8 August 2022
Researchers at the Ineos Oxford Institute for Antimicrobial Resistance (IOI) and the Department of Biology have revealed links between the presence of bacteria that is resistant to antibiotics in mothers and their newborn babies, drawing on data from seven low- and middle-income countries in Africa and South Asia.
Professor Samuel Sheppard, to join Ineos Oxford Institute to further interdisciplinary research on antimicrobial resistance
29 June 2022
Professor Sheppard will join the Department of Biology and the IOI in September 2022, with the aim of using fundamental evolutionary and ecological theory to address consequential questions in pathogen emergence and spread.
8 June 2022
A study published today in Cell Reports reveals how populations of a bacterium called Pseudomonas respond to being treated with Colistin, a 'last resort' antibiotic for patients who have developed multi-drug resistant infections.
1 June 2022
Funding to train the next generation of cutting-edge antimicrobial resistance researchers has been announced by Ineos Oxford Institute (IOI), the University of Oxford, and the University of Cambridge.
6 January 2022
Scientists have found evidence that a type of the antibiotic resistant superbug MRSA arose in nature long before the use of antibiotics in humans and livestock, which has traditionally been blamed for its emergence.
14 December 2021
Scientists have discovered a new potential treatment that has the ability to reverse antibiotic resistance in bacteria that cause conditions such as sepsis, pneumonia, and urinary tract infections.
New research provides compelling evidence of the connection between AMR surgical-site infections and arthropods
30 September 2021
AMR could render many of the current mainstay and last-resort antibiotics useless, resulting in many more deaths from previously treatable infections. In 2019, a UN report estimated that drug-resistant microbes could lead to ten million deaths per year, and cost the world $100trn, by 2050.
10 August 2021
Information about the most effective antibiotics to use in low and middle income countries (LMICs) for neonatal sepsis has been discovered uniquely combining epidemiological, genomic and pharmacodynamic data.
9 June 2021
A cross-disciplinary team from the Universities of Oxford, Ulster and UCL have announced major funding from EPSRC to tackle the growing challenge of Antimicrobial Resistance (AMR).